Medical Condition News

RSS

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.

12 Jan 2010

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).

12 Jan 2010

BioTrends Research Group releases Wave One LaunchTrends: EXTAVIA report

BioTrends Research Group, Inc. announces the release of the Wave One LaunchTrends(®): EXTAVIA report. The survey was completed by U.S. Neurologists Extavia (Interferon beta 1b).

12 Jan 2010

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

New research has shown that reducing the dosage of dopamine agonist (DA) drugs, a mainstay treatment for Parkinson's disease (PD), sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts -- including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications.

12 Jan 2010

Ongoing pressures of human evolution could explain rise in disorders; scientists call for broader perspective

The subtle but ongoing pressures of human evolution could explain the seeming rise of disorders such as autism, autoimmune diseases, and reproductive cancers, researchers write in the Proceedings of the National Academy of Sciences.

12 Jan 2010

Spinal cement may help multiple myeloma patients live longer

New technologies used to repair spinal fractures could soon be helping patients suffering from the bone marrow cancer multiple myeloma.

12 Jan 2010

Soccer-specific exercise program may prevent knee injuries in young female players

A soccer-specific exercise program that includes individual instruction of athletes appears to reduce the risk of knee injuries in young female players, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Jan 2010

Obese patients at greater risk of developing renal cell cancer

Being obese could lead to a greater risk of developing the most common form of renal cell cancer, according to research in the January issue of the UK-based urology journal BJUI.

12 Jan 2010

15% of parents still experience post traumatic stress disorder six months after child's injury

According to research by The Children's Hospital of Philadelphia (CHOP) recently published in the Journal of Traumatic Stress, one month after their child was injured 27 percent of parents experienced acute stress disorder or significant traumatic stress symptoms, including re-experiencing the incident, avoiding reminders of the incident, and increased general anxiety or jumpiness.

12 Jan 2010

New report on launch trend of Roche's Actemra

BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends®: ACTEMRA. Roche, Inc. announced that they received FDA approval for Actemra (generic name: tocilizumab) on January 8th. This represents the first IL-6 receptor inhibitor agent approved for Rheumatoid Arthritis (RA); Actemra is approved for adult patients with moderately-to-severely active RA who have had an inadequate response to one or more TNF antagonist therapies. Actemra represents the fourth IV Infusion product in the RA Market and the first infusion product with monthly maintenance dosing.

12 Jan 2010

Abe's Garden raises $3.5M to include a facility to care for adults with Alzheimer's disease

Abe's Garden, a non-profit organization that seeks to establish a national model of residential living and daycare programs for those suffering with Alzheimer's disease, has raised $3.5 million toward its $9 million capital campaign announced today.

12 Jan 2010

Tocotrienol form of vitamin E prevents neural cell death and rescues the brain after stroke injury

Blocking the function of an enzyme in the brain with a specific kind of vitamin E can prevent nerve cells from dying after a stroke, new research suggests.

12 Jan 2010

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Amicus Therapeutics today outlined the Company's three key strategic priorities and presented a corporate outlook for 2010 at the 28th Annual J.P. Morgan Healthcare Conference.

12 Jan 2010

National Salt Reduction Initiative unveils proposed targets to reduce salt levels in packaged and restaurant foods

The National Salt Reduction Initiative, a New York City-led partnership of cities, states and national health organizations, today unveiled its proposed targets to guide a voluntary reduction of salt levels in packaged and restaurant foods.

12 Jan 2010

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

The public, including parents of babies with severe heart defects, are invited to submit questions for inclusion in a tweet chat about surgical approaches for heart defects from noon-2 p.m. Wednesday, Jan. 20 on Twitter.

12 Jan 2010

Mango effective against colon and breast cancer

Mango. If you know little about this fruit, understand this: It's been found to prevent or stop certain colon and breast cancer cells in the lab.

12 Jan 2010

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardipine hydrochloride) is significantly more effective than intravenous labetalol for the management of blood pressure (BP) in stroke patients.

12 Jan 2010

Obese white men with diabetes face worse outcomes following radical prostatectomy

Obese white men who have both diabetes and prostate cancer have significantly worse outcomes following radical prostatectomy than do men without diabetes who undergo the same procedure, according to research from Duke University Medical Center appearing in Cancer Epidemiology, Biomarkers & Prevention

12 Jan 2010

Mind/body techniques could help patients with celiac disease adhere to gluten-free diet

For adults and children diagnosed with celiac disease, the only treatment is a gluten-free diet, which can be very challenging. Gastroenterologists at Rush University Medical Center are conducting a new study to see if mind/body techniques could help patients with celiac disease adhere to the very strict diet.

12 Jan 2010

Gunshot and stab victims face increased risk of death with prehospital spine immobilization

Immobilizing the spines of shooting and stabbing victims before they are taken to the hospital — standard procedure in Maryland and some other parts of the country — appears to double the risk of death compared to transporting patients to a trauma center without this time-consuming, on-scene medical intervention, according to a new study by Johns Hopkins researchers.

12 Jan 2010

Medical Condition News

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

BioTrends Research Group releases Wave One LaunchTrends: EXTAVIA report

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

Ongoing pressures of human evolution could explain rise in disorders; scientists call for broader perspective

Spinal cement may help multiple myeloma patients live longer

Soccer-specific exercise program may prevent knee injuries in young female players

Obese patients at greater risk of developing renal cell cancer

15% of parents still experience post traumatic stress disorder six months after child's injury

New report on launch trend of Roche's Actemra

Abe's Garden raises $3.5M to include a facility to care for adults with Alzheimer's disease

Tocotrienol form of vitamin E prevents neural cell death and rescues the brain after stroke injury

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

National Salt Reduction Initiative unveils proposed targets to reduce salt levels in packaged and restaurant foods

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

Mango effective against colon and breast cancer

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

Obese white men with diabetes face worse outcomes following radical prostatectomy

Mind/body techniques could help patients with celiac disease adhere to gluten-free diet

Gunshot and stab victims face increased risk of death with prehospital spine immobilization

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News